Table 2.
Characteristics | Value |
---|---|
NIHSS score on admission: | 7.5 (5,14) |
<14 | 36 (65.5%) |
≥14 | 14 (25.4%) |
n.a. | 5 (9.1%) |
Therapy: | |
Yes | 31 (56.4%) |
n.a. | 8 (14.5%) |
TOAST: | |
Atherombotic | 6 (10.9%) |
Cardioembolic | 21 (38.2%) |
Lacunar | 2 (3.7%) |
Indeterminate | 16 (29.1%) |
n.a. | 10 (18.1%) |
Hemisphere of stroke: | |
Right | 22 (40.0%) |
Left | 23 (41.8%) |
Bilateral | 3 (5.5%) |
n.a. | 7 (12.7%) |
Circle segments: | |
Anterior | 42 (76.4%) |
Posterior | 6 (10.9%) |
n.a. | 7 (12.7%) |
Modified Rankin score at 3 months: | 2.95 ±2.5 |
0–2 | 20 (36.4%) |
3–5 | 10 (18.2%) |
6 | 13 (23.6%) |
n.a. | 12 (21.8%) |
NIHSS on admission is expressed as median (Q1, Q3) because values were not normally distributed. Modified Rankin scale at three months is reported as mean ± standard deviation. NIHSS: National Institutes of Health Stroke Scale; TOAST: Trial of Org 10172 in Acute Stroke Treatment (classification of stroke subtypes based on etiology as a main criterion).